Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An announcement from Dr Reddy’s Laboratories ( (RDY) ) is now available.
Dr. Reddy’s Laboratories announced their participation in an investor conference organized by Old Bridge Capital Management on February 5, 2025, in Hyderabad. This engagement with investors suggests an effort to bolster investor relations and transparency, potentially impacting the company’s market perception and stakeholder confidence.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories is a prominent pharmaceutical company based in Hyderabad, India. It specializes in the production of generic medications, active pharmaceutical ingredients, and biologics, with a strong focus on both emerging and regulated markets.
YTD Price Performance: -13.66%
Average Trading Volume: 1,535,272
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $11.36B
For detailed information about RDY stock, go to TipRanks’ Stock Analysis page.
